首页 > 市场调查报告书 > 製药

开发平台分析

市场调查报告书

商品编码

1741432

西尼罗河病毒 (WNV) 市场按产品类型、给药途径、分销管道和地区划分

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

简介目录

西尼罗河病毒 (WNV) 市场规模预计在 2025 年为 7.42 亿美元，预计到 2032 年将达到 12.799 亿美元，2025 年至 2032 年的复合年增长率为 8.1%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	7.42亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	8.10%	2032年价值预测	12.799亿美元

西尼罗河病毒 (WNV) 是一种由蚊子传播的疾病，可感染人类、鸟类和其他动物。该病毒于 1937 年在乌干达西尼罗河地区首次发现，此后传播至世界各地，包括北美、欧洲和亚洲。该病毒主要透过受感染蚊子的叮咬传播给人类。 WNV 可引起一系列症状，从轻微的类流感症状到严重的神经系统疾病，例如脑炎和脑膜炎。大多数感染者不会出现任何症状，但约 20% 的人可能会发烧、头痛、身体疼痛、噁心、呕吐和皮疹。在极少数情况下，WNV 可能致命。

市场动态：

全球西尼罗河病毒 (WNV) 市场受到多种因素驱动。西尼罗河病毒感染发生率的上升，尤其是在北美和欧洲，是市场成长的主要驱动力之一。此外，人们对该疾病及其预防和诊断的认识不断提高也促进了市场扩张。例如，根据美国疾病管制与预防中心 (CDC) 的数据，向国家监测系统报告的西尼罗河病毒 (WNV) 神经侵入性疾病病例数从 2021 年的 2,000 多例增加到 2022 年的 2,500 多例。德克萨斯州、加州、路易斯安那州、内布拉斯加州和伊利诺州等州的病例数最多。病毒的传播可能是由于气候变迁引起的气温上升，这延长了感染季节并扩大了传播病毒的蚊子的地理范围。

然而，有几个因素阻碍了市场的成长。有效治疗方法和疫苗的有限性是对抗西尼罗河病毒的一大挑战。诊断和治疗的高成本也进一步阻碍了市场的成长。

儘管面临诸多挑战，市场参与企业仍有机会。新兴经济体的高成长潜力、有效治疗方法的开发以及蚊虫控制方法的日益普及，都提供了巨大的成长机会。此外，製药公司与研究机构之间的合作可以加速开发针对西尼罗河病毒的创新解决方案。

本研究的主要特点

本报告对全球西尼罗河病毒 (WNV) 市场进行了详细分析，并以 2024 年为基准年，展示了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
它还揭示了不同领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，对全球西尼罗河病毒 (WNV) 市场的主要企业进行了概述。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过用于分析全球西尼罗河病毒 (WNV) 市场的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 742.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.10%	2032 Value Projection:	USD 1,279.9 Mn

West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 and has since spread to many parts of the world, including North America, Europe, and Asia. The virus is primarily transmitted to humans through the bite of infected mosquitoes. WNV can cause a range of symptoms, from mild flu-like illness to severe neurologic diseases such as encephalitis and meningitis. While most infected individuals do not develop any symptoms, around 20% may experience fever, headache, body aches, nausea, vomiting, and rash. In rare cases, WNV can be fatal.

Market Dynamics:

The global West Nile virus market is driven by various factors. The rising incidence of WNV infections, especially in North America and Europe, is one of the primary drivers of market growth. Increasing awareness about the disease, its prevention, and diagnostics is also contributing to market expansion. For instance, according to data from the Centers for Disease Control and Prevention (CDC), the number of West Nile virus neuroinvasive disease cases reported to the national surveillance system increased from over 2000 cases in 2021 to over 2500 cases in 2022. States such as Texas, California, Louisiana, Nebraska, and Illinois witnessed the highest number of cases. The growing prevalence of the virus can be attributed to rising temperatures linked to climate change that are extending the transmission season and expanding the geographical range of mosquitoes that can spread the virus.

However, there are certain restraints hampering the growth of the market. The limited availability of effective treatments and vaccines is a major challenge in combating WNV. High costs associated with diagnosis and treatment further hinder market growth.

Despite these challenges, there are opportunities for market players to capitalize on. High growth potential in emerging economies, development of effective treatment options and rising usage of mosquito control methods presents a significant opportunity for growth. In addition, collaborations between pharmaceutical companies and research institutes can accelerate the development of innovative solutions for WNV.

Key features of the study:

This report provides in-depth analysis of the global West Nile virus market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global West Nile virus market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi, Pfizer, GlaxoSmithKline, Merck, AstraZeneca, Johnson & Johnson, F. Hoffmann-La Roche, Novartis, Cipla, and Gilead Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global West Nile virus market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global West Nile virus market

Detailed Segmentation:

By Product Type:
- Antivirals
- Vaccines
- Antibiotics
- Analgesics
- Others (Immunoglobulins and among Others)
By Route of Administration:
- Oral
- Injectable
- Topical
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Sanofi
- Pfizer
- GlaxoSmithKline
- Merck
- AstraZeneca
- Johnson & Johnson
- Hoffmann-La Roche
- Novartis
- Cipla
- Gilead Scienes

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global West Nile Virus Market, By Product Type
- Global West Nile Virus Market, By Route of Administration
- Global West Nile Virus Market, By Distribution Channel
- Global West Nile Virus Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
Epidemiology
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antivirals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)
Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration , 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
Africa

9. Competitive Landscape

Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Johnson & Johnson
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
F.Hoffmann-La Roche
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Cipla
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Gilead Sciences
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

西尼罗河病毒 (WNV) 市场按产品类型、给药途径、分销管道和地区划分

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

市场动态：

本研究的主要特点

目录

第一章调查目的与前提条件

第二章市场展望

第三章市场动态、法规与趋势分析

4. 全球西尼罗河病毒 (WNV) 市场-冠状病毒 (COVID-19) 大流行的影响

5. 2020 年至 2032 年全球西尼罗河病毒 (WNV) 市场（依产品类型）

6. 2020 年至 2032 年按给药途径分類的全球西尼罗河病毒 (WNV) 市场

7. 2020 年至 2032 年全球西尼罗河病毒 (WNV) 市场按通路划分

8. 2020 年至 2032 年全球西尼罗河病毒 (WNV) 市场（按地区）

第九章竞争态势

第 10 章章节

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

9. Competitive Landscape

10. Section

西尼罗河病毒 (WNV) 市场按产品类型、给药途径、分销管道和地区划分

West Nile Virus Market, By Product Type, By Route of Administration, By Distribution Channel, By Region

市场动态：

本研究的主要特点

目录

第一章 调查目的与前提条件

第二章 市场展望

第三章市场动态、法规与趋势分析

4. 全球西尼罗河病毒 (WNV) 市场-冠状病毒 (COVID-19) 大流行的影响

5. 2020 年至 2032 年全球西尼罗河病毒 (WNV) 市场（依产品类型）

6. 2020 年至 2032 年按给药途径分類的全球西尼罗河病毒 (WNV) 市场

7. 2020 年至 2032 年全球西尼罗河病毒 (WNV) 市场按通路划分

8. 2020 年至 2032 年全球西尼罗河病毒 (WNV) 市场（按地区）

第九章 竞争态势

第 10 章 章节

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global West Nile Virus Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global West Nile Virus Market, By Product Type, 2020-2032, (US$ Mn)

6. Global West Nile Virus Market, By Route of Administration , 2020-2032, (US$ Mn)

7. Global West Nile Virus Market, By Distribution Channel, 2020-2032, (US$ Mn)

8. Global West Nile Virus Market, By Region, 2020-2032, (US$ Mn)

9. Competitive Landscape

10. Section

第一章调查目的与前提条件

第二章市场展望

第九章竞争态势

第 10 章章节